UNLEASH THE PROMISE OF IMMUNOTHERAPY IN COLD TUMORS
* RE-PROGRAM the Tumor Microenvironment (TME) from immunosuppresive TO IMMUNO-COMPETENT (COLD to HOT activation). Engineered cellular constructs derived from non-pathogenic-in-Man eukaryote cell types have shown, in extensive murine studies, outstanding efficiency in regressing, even eradicating, tumors. Novel, proprietary mechanisms of action (MOA) transform the TME to an immune competent state.
* DELIVER MOLECULAR THERAPEUTICS INTO CANCER CELLS, unimpeded by TME barriers. Kymeris’ platform is also programmable technology that already has multiple in-house derivatives that deliver molecules of therapeutic interest (antigen, therapeutic proteins or antibody) to and through the TME and into cancer cells. Expression can be membrane-bound or secreted.
Our strategy is to pursue both in-house products and also, in co-operation with pharmaceutical / biotechnology companies, to improve delivery of their molecules for better therapeutic outcomes.
The Company: Kymeris is a pre-clinical immuno-oncology company whose novel platform technology focuses on improving solid cancer cure rates.
It is is a founder-controlled private corporation with development activities carried out in Europe and in the United States. It now seeks its first round of exterior financing.
Company Details
- Founded
- -
- Address
- 22 Adelaide St W, Suite 3400,france
- Phone
- 305 680 6400
- in****@****srx.com
- Industry
- Biotechnology
- Website
- kymeris.net
- Keywords
- cancer, immunotherapy, oncology, biopharmaceutical, pharmaceutical, carcinoma, solid state cancer, solid state tumor, inoperable cancer, CUP, disseminated cancer, metastasis, metastases, ovarian cancer, lymphoma, melanoma, cancer vaccine, oncolytic, immunostimulant, glioblastoma, solid tumor, solid tumour, immunotherapy, immunooncology, oncotherapy, oncolytic, microbial, cellular, eukaryote.
- HQ
- Toronto, Ontario
Kymeris Therapeutics And Kymeris Santé Questions
Kymeris Therapeutics And Kymeris Santé's helpline number is 305 680 6400
Kymeris Therapeutics And Kymeris Santé's website is kymeris.net
Kymeris Therapeutics And Kymeris Santé's LinkedIn profile is https://ca.linkedin.com/company/kymeris-therapeutics-inc
Kymeris Therapeutics And Kymeris Santé's industry is
Biotechnology
Kymeris Therapeutics And Kymeris Santé's top competitors are
Learngmp,
Lifescreen,
Freshleaf Marketing,
Kymeris Sante,
Synthetic Biology Innovation Cluster,
Unisyn Labs,
Kelvin Grove Biotechnology,
Lomeli Cannabis,
Genomics Insight,
Spydiag.
Kymeris Therapeutics And Kymeris Santé's support email address is info@kymerisrx.com
Kymeris Therapeutics And Kymeris Santé's categories are Biotechnology
Kymeris Therapeutics And Kymeris Santé's founding year is 2017
